Results 191 to 198 of about 2,198,200 (198)
Some of the next articles are maybe not open access.
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
Science, 2007The epidermal growth factor receptor (EGFR) kinase inhibitors gefitinib and erlotinib are effective treatments for lung cancers with EGFR activating mutations, but these tumors invariably develop drug resistance.
J. Engelman+18 more
semanticscholar +1 more source
Revisions in the International System for Staging Lung Cancer.
Chest, 1997Revisions in stage grouping of the TNM subsets (T=primary tumor, N=regional lymph nodes, M=distant metastasis) in the International System for Staging Lung Cancer have been adopted by the American Joint Committee on Cancer and the Union Internationale ...
C. Mountain
semanticscholar +1 more source
The global burden of lung cancer: current status and future trends
Nature Reviews Clinical Oncology, 2023A. Leiter, R. Veluswamy, J. Wisnivesky
semanticscholar +1 more source
The biology and management of non-small cell lung cancer
Nature, 2018R. Herbst, D. Morgensztern, C. Boshoff
semanticscholar +1 more source
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Nature, 2007M. Soda+17 more
semanticscholar +1 more source
Phenotype molding of stromal cells in the lung tumor microenvironment
Nature Network Boston, 2018D. Lambrechts+17 more
semanticscholar +1 more source